Newpath targets $250m for sophomore fund

Newpath Partners is seeking to raise $250 million for its second fund, according to an SEC filing.

Newpath Partners is seeking to raise $250 million for its second fund, according to an SEC filing. Newpath is a Boston-based life science venture firm.

Source: SEC filing